SCHEMBL2855140

SCHEMBL2855140

Cc1ccccc1-n1nnnc1C(Cl)(Cl)C(=O)Nc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
TSHR P16473 1/20 0.46
MAPK13 O15264 1/20 0.46
MAPK12 P53778 1/20 0.46
MAPK11 Q15759 1/20 0.46
MAPK14 Q16539 1/20 0.46
HSD11B1 P28845 1/20 0.45
LMNA P02545 4/20 0.41
HTT P42858 3/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.40
MAPT P10636 3/20 0.40
ABCB1 P08183 1/20 0.39
HPGD P15428 3/20 0.39
CCR6 P51684 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2846340 0.92 TYK2 (0.42) ALDH1A1TSHRMAPK13MAPK12MAPK11
SCHEMBL13354144 0.87 MAPK13 (0.49) ALDH1A1TSHRMAPK13MAPK12MAPK11
SCHEMBL2853837 0.84 ALDH1A1 (0.57) ALDH1A1LMNAHTTKMT2AMEN1
SCHEMBL2851627 0.83 ALDH1A1 (0.43) ALDH1A1TSHRHSD11B1LMNAHTT
SCHEMBL13354145 0.82 TYK2 (0.41) ALDH1A1TSHRMAPK13MAPK12MAPK11
SCHEMBL2843430 0.81 ALDH1A1 (0.53) ALDH1A1TSHRMAPK14HSD11B1LMNA
SCHEMBL2846682 0.79 ALDH1A1 (0.46) ALDH1A1TSHRHSD11B1LMNAHTT
SCHEMBL2008495 0.76 ALDH1A1 (0.60) ALDH1A1TSHRHSD11B1LMNAHTT
SCHEMBL13354146 0.75 ALDH1A1 (0.52) ALDH1A1TSHRMAPK13MAPK12MAPK11
SCHEMBL2850071 0.74 MEN1 (0.47) ALDH1A1TSHRLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130509-A1 NOVEL ANTIBIOTICS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWE- TENSCHAPPELIJK ONDERZOEK TNO (NL) 2010-05-27 US disclosed
EP-2139872-A1 NOVEL ANTIBIOTICS Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO (NL) 2010-01-06 EP disclosed
WO-2008120992-A1 NOVEL ANTIBIOTICS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2008-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130509-A1 NOVEL ANTIBIOTICS TMEM165, LAS1L, RPS2 ALDH1A1 4431/4885TSHR 3686/4885MAPK13 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.